Product NDC: | 61748-045 |
Proprietary Name: | Aminocaproic Acid |
Non Proprietary Name: | Aminocaproic Acid |
Active Ingredient(s): | 500 mg/1 & nbsp; Aminocaproic Acid |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 61748-045 |
Labeler Name: | VersaPharm Incorporated |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075602 |
Marketing Category: | ANDA |
Start Marketing Date: | 20010801 |
Package NDC: | 61748-045-01 |
Package Description: | 100 TABLET in 1 BOTTLE (61748-045-01) |
NDC Code | 61748-045-01 |
Proprietary Name | Aminocaproic Acid |
Package Description | 100 TABLET in 1 BOTTLE (61748-045-01) |
Product NDC | 61748-045 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Aminocaproic Acid |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20010801 |
Marketing Category Name | ANDA |
Labeler Name | VersaPharm Incorporated |
Substance Name | AMINOCAPROIC ACID |
Strength Number | 500 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE] |